51 related articles for article (PubMed ID: 31617267)
21. SMARCB1 regulates the hypoxic stress response in sickle cell trait.
Soeung M; Perelli L; Chen Z; Dondossola E; Ho IL; Carbone F; Zhang L; Khan H; Le CN; Zhu C; Peoples MD; Feng N; Jiang S; Zacharias NM; Minelli R; Shapiro DD; Deem AK; Gao S; Cheng EH; Lucchetti D; Walker CL; Carugo A; Giuliani V; Heffernan TP; Viale A; Tannir NM; Draetta GF; Msaouel P; Genovese G
Proc Natl Acad Sci U S A; 2023 May; 120(21):e2209639120. PubMed ID: 37186844
[TBL] [Abstract][Full Text] [Related]
22. A case of renal cell carcinoma unclassified with medullary phenotype without detectable gene deletion.
Tsuzuki S; Kataoka TR; Ito H; Ueshima C; Asai S; Yokoo H; Haga H
Pathol Int; 2019 Dec; 69(12):710-714. PubMed ID: 31617267
[TBL] [Abstract][Full Text] [Related]
23. A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary Carcinoma.
Msaouel P; Tannir NM; Walker CL
Clin Cancer Res; 2018 May; 24(9):2044-2049. PubMed ID: 29440190
[TBL] [Abstract][Full Text] [Related]
24. [SMARCB1(INI1)-deficient renal cell carcinoma: medullary and beyond : Evolving concepts].
Agaimy A; Hartmann A
Pathologe; 2021 Nov; 42(6):571-577. PubMed ID: 34609565
[TBL] [Abstract][Full Text] [Related]
25. Recent Advances in Renal Medullary Carcinoma.
Su Y; Hong AL
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806102
[TBL] [Abstract][Full Text] [Related]
26. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
Pawel BR
Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
[TBL] [Abstract][Full Text] [Related]
27. Approach for reclassification of collecting duct carcinoma and comparative histopathological analysis with SMARCB1/INI1-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma.
Kiyozawa D; Kohashi K; Takamatsu D; Iwasaki T; Shibata D; Tomonaga T; Tateishi Y; Eto M; Kinjo M; Nishiyama K; Taguchi K; Oshiro Y; Kuboyama Y; Furuya M; Oda Y
Hum Pathol; 2022 Jun; 124():36-44. PubMed ID: 35306021
[TBL] [Abstract][Full Text] [Related]
28. Renal Medullary Carcinoma: a Report of the Current Literature.
Blas L; Roberti J; Petroni J; Reniero L; Cicora F
Curr Urol Rep; 2019 Jan; 20(1):4. PubMed ID: 30656488
[TBL] [Abstract][Full Text] [Related]
29. SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review.
Agaimy A; Rau TT; Hartmann A; Stoehr R
Am J Surg Pathol; 2014 Jul; 38(7):910-20. PubMed ID: 24503755
[TBL] [Abstract][Full Text] [Related]
30. High grade infiltrative adenocarcinomas of renal cell origin: New insights into classification, morphology, and molecular pathogenesis.
Singh JA; Ohe C; Smith SC
Pathol Int; 2018 May; 68(5):265-277. PubMed ID: 29665139
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic challenges of renal medullary carcinoma and the role for cytologic assessment: Case report and literature review.
Severseike BO; Schafernak KT; Willard SD; Goncalves LF; Kothari AK; Eshun FK; Mangum R
J Clin Lab Anal; 2023 Apr; 37(4):e24854. PubMed ID: 36843202
[TBL] [Abstract][Full Text] [Related]
32. Pathology and diagnosis of SMARCB1-deficient tumors.
Margol AS; Judkins AR
Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
[TBL] [Abstract][Full Text] [Related]
33. Gene of the month: SMARCB1.
Kalimuthu SN; Chetty R
J Clin Pathol; 2016 Jun; 69(6):484-9. PubMed ID: 26941181
[TBL] [Abstract][Full Text] [Related]
34. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.
Agaimy A
Adv Anat Pathol; 2014 Nov; 21(6):394-410. PubMed ID: 25299309
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic and Molecular Pathology of Collecting Duct Carcinoma and Related Renal Cell Carcinomas.
Seo AN; Yoon G; Ro JY
Adv Anat Pathol; 2017 Mar; 24(2):65-77. PubMed ID: 28181950
[TBL] [Abstract][Full Text] [Related]
36. Poorly differentiated chordoma with loss of SMARCB1/INI1 expression in pediatric patients: A report of two cases and review of the literature.
Cha YJ; Hong CK; Kim DS; Lee SK; Park HJ; Kim SH
Neuropathology; 2018 Feb; 38(1):47-53. PubMed ID: 28812319
[TBL] [Abstract][Full Text] [Related]
37. Kidney cancer: Classifying the unclassified - molecular analysis of uRCC.
Stone L
Nat Rev Urol; 2016 Dec; 13(12):691. PubMed ID: 27779226
[No Abstract] [Full Text] [Related]
38. High-grade carcinomas involving the renal sinus: report of a case and review of the differential diagnosis and immunohistochemical expression.
Young A; Kunju LP
Arch Pathol Lab Med; 2012 Aug; 136(8):907-10. PubMed ID: 22849739
[TBL] [Abstract][Full Text] [Related]
39. Renal Medullary Carcinoma: Establishing Standards in Practice.
Beckermann KE; Sharma D; Chaturvedi S; Msaouel P; Abboud MR; Allory Y; Bourdeaut F; Calderaro J; de Cubas AA; Derebail VK; Hong AL; Naik RP; Malouf GG; Mullen EA; Reuter VE; Roberts CWM; Walker CL; Wood CG; DeBaun MR; Van Poppel H; Tannir NM; Rathmell WK
J Oncol Pract; 2017 Jul; 13(7):414-421. PubMed ID: 28697319
[TBL] [Abstract][Full Text] [Related]
40. Review of renal cell carcinoma with rhabdoid features with focus on clinical and pathobiological aspects.
Kuroda N; Karashima T; Inoue K; Kasajima A; Ohe C; Kawakami F; Mikami S; Matsuura K; Moriyama M; Nagashima Y; Petersson F; Lopez JI; Cohen RJ; Michal M; Hes O
Pol J Pathol; 2015 Mar; 66(1):3-8. PubMed ID: 26017874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
